Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pamela DiPiro, M.D.

Concepts (192)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Referral and Consultation5202336030.910 Why?
Oncology Service, Hospital22017570.680 Why?
Carcinoma, Lobular220204800.590 Why?
Abdominal Neoplasms120192870.560 Why?
Breast Neoplasms182023209810.520 Why?
Physician Assistants120181900.510 Why?
Mammography12201824300.500 Why?
Radiology4202321140.440 Why?
Neoplasms, Second Primary2201910510.430 Why?
Fibrocystic Breast Disease520001030.420 Why?
Tomography, X-Ray Computed132023206000.400 Why?
Biopsy, Needle8200016240.370 Why?
Academic Medical Centers5202327570.360 Why?
Lymphoma, Large B-Cell, Diffuse2201714050.310 Why?
Breast8200019630.310 Why?
Radiology Information Systems320215290.290 Why?
Cancer Care Facilities220184220.290 Why?
Inflammatory Breast Neoplasms220201470.290 Why?
Lymphoma, T-Cell120093030.270 Why?
Medical Oncology1201823160.270 Why?
Liver Neoplasms2202043080.270 Why?
Neoplasm Metastasis3201649080.250 Why?
Evidence-Based Medicine1201736890.240 Why?
Radiology Department, Hospital220194070.220 Why?
Ultrasonography, Mammary520182390.210 Why?
Magnetic Resonance Imaging72021364180.210 Why?
Genes, erbB-2220141620.200 Why?
Carcinoma, Ductal, Breast5202010840.190 Why?
Stereotaxic Techniques520005550.190 Why?
Fluorodeoxyglucose F182202020250.180 Why?
Forms and Records Control120201580.160 Why?
Incidental Findings220206980.150 Why?
Calcinosis5200014770.150 Why?
Multiple Pulmonary Nodules120201730.150 Why?
Calcium Phosphates120181710.140 Why?
Surgical Instruments119993830.140 Why?
Solitary Pulmonary Nodule120202790.140 Why?
Workload120028440.140 Why?
Retrospective Studies182023806730.130 Why?
Environment1200211210.130 Why?
Tumor Burden2201418920.130 Why?
Lung Neoplasms62020133820.130 Why?
Neoplasms52017221250.130 Why?
Quality Improvement3202038010.130 Why?
Foreign Bodies119994020.120 Why?
Immunoconjugates120239630.120 Why?
Seat Belts11995600.120 Why?
Humans5020237610980.120 Why?
Patient Care Planning120209040.120 Why?
Positron-Emission Tomography4201765850.120 Why?
Neoplasm Recurrence, Local4201792780.120 Why?
Receptors, Progesterone2202011290.110 Why?
Female3720233924580.110 Why?
Terminology as Topic1202015280.100 Why?
Clinical Protocols1201814360.100 Why?
Radiopharmaceuticals2202026820.100 Why?
Carcinoma, Intraductal, Noninfiltrating119999260.100 Why?
Receptor, erbB-23202325530.100 Why?
Receptors, Estrogen2202022080.090 Why?
Genes, BRCA1120147540.090 Why?
Interprofessional Relations120179890.090 Why?
Mucous Membrane120136590.090 Why?
Quinazolines2201413710.090 Why?
Breast Diseases319984430.090 Why?
Immunoblastic Lymphadenopathy12009400.080 Why?
Pleural Neoplasms120146090.080 Why?
Prognosis42019296720.080 Why?
Accidents, Traffic119958150.080 Why?
Survival Analysis22019100830.080 Why?
Contrast Media3201853110.080 Why?
Leukemia-Lymphoma, Adult T-Cell120091640.080 Why?
Neoplasm Staging72020111180.080 Why?
Middle Aged2520202208350.080 Why?
Pulmonary Embolism2201225710.080 Why?
Delivery of Health Care, Integrated120169400.070 Why?
Aged2120201692660.070 Why?
Lymphoma, Large-Cell, Anaplastic120091680.070 Why?
Follow-Up Studies62020391210.070 Why?
Nose Neoplasms120092490.070 Why?
Decision Support Techniques1201720000.070 Why?
Hodgkin Disease1201413780.070 Why?
Patient-Centered Care1201714240.070 Why?
Cone-Beam Computed Tomography120104740.070 Why?
Central Nervous System Neoplasms120149150.070 Why?
Adult2120202210830.060 Why?
Melanoma2201456940.060 Why?
Molecular Targeted Therapy1201728130.060 Why?
Diabetes Mellitus, Type 11199934160.060 Why?
Uterine Cervical Neoplasms1201620200.060 Why?
Carcinoma, Non-Small-Cell Lung2201453180.060 Why?
Carcinoma in Situ220007910.060 Why?
Aged, 80 and over92019589460.050 Why?
Antineoplastic Combined Chemotherapy Protocols22014117320.050 Why?
Radiation Injuries1201011910.050 Why?
Boston3201993240.050 Why?
Brachytherapy1201012230.050 Why?
Physicians1202045830.050 Why?
Mass Screening1201854250.050 Why?
Bone Neoplasms1201425270.050 Why?
Iohexol220142050.050 Why?
Radiography2202369750.050 Why?
Brain Neoplasms1202390250.050 Why?
Diagnosis, Differential32020129750.050 Why?
Camptothecin120235910.040 Why?
Gastrointestinal Stromal Tumors120056170.040 Why?
Antineoplastic Agents32017136300.040 Why?
Medical Record Linkage120192860.040 Why?
Workflow120228500.040 Why?
Radiographic Image Enhancement220148770.040 Why?
Treatment Outcome72023646700.040 Why?
Ultrasonography, Interventional2200214960.040 Why?
Negotiating120181510.030 Why?
Carcinoma, Squamous Cell1201240210.030 Why?
Radiographic Magnification11996190.030 Why?
Male1120173606750.030 Why?
Fibroadenoma11996410.030 Why?
Axilla120186240.030 Why?
Comprehensive Health Care120161230.030 Why?
Fat Necrosis11995600.030 Why?
Adenocarcinoma1201263400.030 Why?
Contusions11995790.030 Why?
Risk2201896140.030 Why?
Piperazines1200525220.030 Why?
Radiography, Interventional2199911220.030 Why?
Evaluation Studies as Topic1199616240.030 Why?
Data Collection1200233190.030 Why?
Pyrimidines1200530260.030 Why?
Antibodies, Neoplasm120142820.030 Why?
Lymph Node Excision1201812690.030 Why?
Models, Organizational120165440.030 Why?
Cysts119976800.020 Why?
Vinblastine120134880.020 Why?
Kaplan-Meier Estimate2201264820.020 Why?
Markov Chains120149650.020 Why?
Maytansine12011860.020 Why?
Mastectomy, Segmental119969550.020 Why?
Radiotherapy, Adjuvant1199617840.020 Why?
Biopsy2199967810.020 Why?
Mastectomy1201818170.020 Why?
Chemotherapy, Adjuvant1201835120.020 Why?
Ultrasonography2200059710.020 Why?
Skin Neoplasms1200958090.020 Why?
Estrogen Replacement Therapy1199612080.020 Why?
Vacuum22000650.020 Why?
Lymphocytes, Tumor-Infiltrating1201410890.020 Why?
Life Expectancy1201412420.020 Why?
Neoadjuvant Therapy1201828270.020 Why?
Risk Factors12014742190.020 Why?
Prospective Studies22023544190.020 Why?
Statistics, Nonparametric1201228550.020 Why?
Angiogenesis Inhibitors1201720470.020 Why?
Drug Administration Schedule1201448490.020 Why?
Lymphatic Metastasis1201329130.020 Why?
Radiation Dosage1201419660.020 Why?
Massachusetts1201888360.020 Why?
Cohort Studies22023414860.020 Why?
Decision Making1201839250.010 Why?
Observer Variation1201026110.010 Why?
Survivors1201423690.010 Why?
Neovascularization, Pathologic1201426350.010 Why?
Time Factors21996399530.010 Why?
Outpatients1201115960.010 Why?
Lymph Nodes1199334610.010 Why?
Dose-Response Relationship, Drug12014107550.010 Why?
Diagnostic Imaging1201635350.010 Why?
Cross-Sectional Studies12002260680.010 Why?
Cost-Benefit Analysis1201454940.010 Why?
Sex Factors12014105520.010 Why?
Biomedical Research1201634290.010 Why?
Recurrence1201284560.010 Why?
Early Detection of Cancer1201431960.010 Why?
Benzamides1200513700.010 Why?
Venous Thromboembolism1201218680.010 Why?
Multivariate Analysis12012120580.010 Why?
Automation120005850.010 Why?
Protein Kinase Inhibitors1201456620.010 Why?
Age Factors12014183850.010 Why?
Smoking1201490550.010 Why?
Hyperplasia1200011500.010 Why?
Image Processing, Computer-Assisted1201490010.010 Why?
Imaging, Three-Dimensional1201040600.010 Why?
Antibodies, Monoclonal1201491850.010 Why?
Anticoagulants1201247950.010 Why?
Reproducibility of Results12014201200.010 Why?
Chi-Square Distribution1200034190.010 Why?
Incidence12011213570.010 Why?
Equipment Design1200035090.010 Why?
Neoplasm Invasiveness1200035910.010 Why?
Lung1201099790.010 Why?
Young Adult12011591990.000 Why?
Case-Control Studies11997221570.000 Why?
Adolescent12005882710.000 Why?
DiPiro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (192)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.